Recent Finacing
Recent Raise
Regulus Therapeutics is a San Diego biopharmaceutical company discovering and developing microRNA-targeted therapeutics for indications including hepatitis C, immuno-inflammatory diseases, fibrosis, oncology, and cardiovascular/metabolic disorders.
Focus Areas
Recent Investors
Total Raised
Funding round
Investor